Crescendo Biologics Ltd.
PrivateLast Round
VC Round
Jul 24, 2023
Total Funding Raised
$179.71M
Company Overview
Crescendo Biologics Ltd. is a biotechnology company that develops novel, targeted T-cell enhancing therapeutics based on its proprietary Humabody® VH platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Crescendo Biologics Ltd. Comparables
Compare Crescendo Biologics Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Leveragen, Inc. | 81% | |
| Isogenica | 80% | |
| AbTherx, Inc. | 79% |
Crescendo Biologics Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 24, 2023 | ||||
| Corporate Funding | Jan 10, 2022 | ||||
| Series B | Apr 30, 2018 | ||||
| VC Round | Dec 16, 2014 | ||||
| Series A | Apr 3, 2014 | ||||
Series A | Dec 17, 2013 |
Crescendo Biologics Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kreos Capital | VC Round |
| IP Group | VC Round, Series B |
| Andera Partners | VC Round, Series B |
| Kreos Capital | VC Round |
| UK Innovation & Science Seed Fund | Seed |
| Imperial Innovations | Series A |
| Astellas Venture Management | VC Round, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2023
$32M raised with participation from Andera Partners and Kreos Capital.
- Jan 10, 2022
$40M round led by BioNTech SE
Crescendo Biologics Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Crescendo Biologics Ltd.'s valuation, stock price, and market status.
Is Crescendo Biologics Ltd. a public or private company?
Crescendo Biologics Ltd. is a private company.
What is the current stock price of Crescendo Biologics Ltd.?
Crescendo Biologics Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Crescendo Biologics Ltd. worth (valuation)?
Valuation information for Crescendo Biologics Ltd. is not publicly available.
Can I buy Crescendo Biologics Ltd. stock?
Crescendo Biologics Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Crescendo Biologics Ltd.'s last funding round?
Crescendo Biologics Ltd.'s most recent funding round was VC Round on July 24, 2023.
Who are the main investors in Crescendo Biologics Ltd.?
Key investors in Crescendo Biologics Ltd. include Andera Partners, Imperial Innovations, Sofinnova Partners.
Will Crescendo Biologics Ltd. IPO soon?
No public IPO plans have been announced for Crescendo Biologics Ltd..
How can I track Crescendo Biologics Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Crescendo Biologics Ltd.'s secondary market activity and sign up for updates.